How Digital PCR Works: A Clear, Practical Guide for 2026

These figures come from the University of Iowa’s droplet digital PCR service page and QIAGEN’s digital PCR bench guide.

How does digital PCR work? It splits a reaction into thousands of nanoliter partitions, amplifies each one, counts positive and negative partitions, and applies Poisson statistics to report absolute copies per microliter without a standard curve.

For background on the field this method belongs to, see what is biotechnology. The sections below start with what the counting approach means for your decisions, then explain the mechanism and the Poisson calculation.

What counting molecules changes in practice

dPCR gives a count of target molecules, and that changes how you plan an experiment. The University of Iowa genomics core describes the technology as ultrasensitive and absolute, with results expressed as copies per microliter. Four decisions follow from that.

• Skip the calibration series for samples. Because the instrument counts target molecules, droplet digital PCR does not require a standard curve to quantify a sample. That saves bench time and removes one source of variation between runs.
• Match the method to the target. The Iowa core finds ddPCR particularly useful for low-abundance targets, targets in complex backgrounds, SNPs and subtle changes in level. If your target is abundant and clean, the advantage is smaller.
• Expect tolerance, not immunity, with difficult samples. QIAGEN describes the technique as more precise and less susceptible to inhibitors, errors and amplification biases. That makes dPCR a reasonable option for demanding samples, but it does not replace assay validation.
• Plan the partition count and loading. The reliability of the count depends on how many partitions the run produces and how many copies each one receives, covered in the limits section below.

Applications and who they suit

Low-abundance targets and complex backgrounds

The clearest fit is a target that is rare or buried in a complex background. The Iowa core lists low-abundance targets, complex backgrounds, SNPs and subtle level changes as the strengths of ddPCR. Teams that need to tell a small shift in level from noise should weigh dPCR first. Teams measuring abundant, well-behaved targets may find it adds little.

Multiplexing and emerging uses

QIAGEN lists analysis of multiple targets in one run, up to 12-plex, as a dPCR capability. A review in a peer-reviewed journal reports that ddPCR may facilitate microRNA measurement, particularly in liquid biopsy, and may aid DNA methylation research. Treat those as promising research uses rather than settled routine practice. Molecular counting tools like this sit within a wider technology landscape that also includes debates such as Cloning Animals: The Real Benefits, Risks, and What Comes Next (2026 Guide) – Biolifetechnologies.

Digital PCR versus qPCR

The main difference is what each method reports. qPCR relies on a standard curve to turn a signal into a quantity. dPCR counts target molecules and gives copies per microliter. The Iowa core notes that, unlike qPCR, ddPCR has no need to generate a standard curve.

A practitioner note on method validation adds a nuance: dPCR requires a standard curve only during the validation phase. So the curve moves from every run to the assay’s validation stage. If your question is relative expression across many samples, the real-time approach explained in How Real-Time PCR Works: A Clear, Practical Guide For 2026 – Biolifetechnologies may serve you well. If your question is how many copies are present, especially at low levels, dPCR answers it more directly.

How partitioning, amplification and counting work

The workflow has three steps, as QIAGEN lays out: partition the sample, amplify and detect, then calculate concentration. The term “digital PCR” was first coined in a study published in 1999, but the logic is the same today.

Partitioning

The reaction mix is divided into thousands of individual partitions. In droplet digital PCR, each molecule of DNA or RNA is partitioned into one of a large number of nanoliter-sized droplets before amplification, and each droplet acts as its own PCR reaction. Chance decides which droplets receive a target. Some receive none, and others receive one or more.

Amplification and detection

Each partition is then amplified. A review describes the approach as using Taq polymerase in a standard polymerase chain reaction to amplify a target fragment. After cycling, the instrument reads each partition and classes it as positive (target present) or negative (no target).

The Poisson calculation

Counting positives alone would undercount molecules, because some partitions hold more than one copy. The Iowa core explains that, using the Poisson distribution law, the fraction of positive droplets is converted to the number of molecules in the starting sample.

QIAGEN shows how the average load per partition, written as lambda (λ), shapes the picture. At λ = 0.1, most partitions hold zero copies. At λ = 5, nearly none are zero. A useful run sits between those extremes, with a mix of empty and positive partitions.

QIAGEN’s worked example uses 4000 positive partitions out of 8000 valid partitions. Applying the Poisson correction gives 3013 copies per microliter. The result is a concentration in the reaction, so reporting it for the original sample means accounting for how much sample went into the reaction.

Planning a run

On the bench, the sequence is: prepare the reaction mix with primers, probe and polymerase, partition it, amplify, read, and let the software apply the Poisson correction. Droplet systems and chip-based systems partition differently, but the partition-amplify-count logic is shared.

On the droplet system at the Iowa core, you transfer 20 µL of PCR reaction into the droplet generator cartridge and prepare 22-25 µL reactions so the transfer is never short. Check your own instrument’s guidance for its loading volume, since other platforms differ.

Limits and validation

The Poisson calculation is only as good as its assumptions. A practitioner guide on dPCR method validation warns that an insufficient number of droplets may not align with Poisson distribution assumptions. The practical response is to set droplet-count acceptance criteria during validation and reject runs that fall short.

• Watch partition quality. Count only valid partitions, as in the QIAGEN example, so failed partitions do not distort the concentration.
• Avoid extreme loading. Very low load leaves most partitions empty, and very high load leaves almost none empty. Adjust the input so the run falls between those extremes.
• Validate before routine use. Treat the standard curve, acceptance criteria and controls as part of setting up a new assay, not as an afterthought.
• Keep claims proportionate. The qualitative advantage over inhibitors and biases is a manufacturer description. Confirm it with your own sample type.

Frequently asked questions